(<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a']二萘-4-基)二(1-苯基乙基)胺 CAS 380230-02-4

(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine 380230-02-4 (+)-N,N-BIS[(1S)-1-PHENYLETHYL]-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE, (11BR);(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A3,4-A']DINAPHTHALEN-4-YL)BIS[(1S)-1-PHENYLETHYL]AMINE;(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS[(1S)-1-PHENYLETHYL]AMINE;(S,S,S)-(+)-(3,5-DIOXA-4-PHOSPHACYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS(1-PHENYLETHYL)AMINE;(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine SC11364

纯度 97%+现货药物标准品
CAS 号380230-02-4
分子式C36H62NO2P
分子量571.86 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a']二萘-4-基)二(1-苯基乙基)胺 (S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine
380230-02-4
(+)-N,N-BIS[(1S)-1-PHENYLETHYL]-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE, (11BR);(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A3,4-A']DINAPHTHALEN-4-YL)BIS[(1S)-1-PHENYLETHYL]AMINE;(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS[(1S)-1-PHENYLETHYL]AMINE;(S,S,S)-(+)-(3,5-DIOXA-4-PHOSPHACYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS(1-PHENYLETHYL)AMINE;(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine
SC11364 CAS 380230-02-4 结构式 Chemical Structure

产品介绍 Description

(<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a']二萘-4-基)二(1-苯基乙基)胺(英文名 (S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine 380230-02-4 (+)-N,N-BIS[(1S)-1-PHENYLETHYL]-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE, (11BR);(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A3,4-A']DINAPHTHALEN-4-YL)BIS[(1S)-1-PHENYLETHYL]AMINE;(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS[(1S)-1-PHENYLETHYL]AMINE;(S,S,S)-(+)-(3,5-DIOXA-4-PHOSPHACYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS(1-PHENYLETHYL)AMINE;(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine SC11364,CAS 380230-02-4)属于药物标准品。分子式 C36H62NO2P,分子量 571.86。纯度 97%+。佳途科技作为 ISO 17034 认可的标准物质生产商,为该产品提供完整的质量文件与技术支持。

从化学结构特征来看,(<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并2,1-a:3,4-a'二萘-4-基)二(1-苯基乙基)胺的分子骨架中包含含氮杂环结构,酰胺类,有机磷,含羟基,含醚键。该化合物的不饱和度为6.5,表明结构中存在约6个环或双键等价单元。分子量为571.86 g/mol,属于较高分子量化合物。较高的碳氢原子比赋予该化合物良好的脂溶性,可使用正己烷或乙酸乙酯等非极性溶剂进行液-液萃取前处理。 (<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并2,1-a:3,4-a'二萘-4-基)二(1-苯基乙基)胺((S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta2,1-a;3,4-a'dinaphthalen-4-yl)bis(1S)-1-phenylethylamine 380230-02-4 (+)-N,N-BIS(1S)-1-PHENYLETHYL-DINAPHTHO2,1-D:1',2'-F1,3,2DIOXAPH

应用场景:在化学分析实验室中,(<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并 2,1-a:3,4-a' 二萘-4-基)二(1-苯基乙基)胺(CAS 380230-02-4)凭借其97%+的纯度做为基础物质,为定量分析提供基准参照。 推荐以(<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并 2,1-a:3,4-a' 二萘-4-基)二(1-苯基乙基)胺配制标准系列工作溶液,用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈(1:1)为溶剂配制储备溶液,根据检测灵敏度需求逐级稀释。 使用建议:

理化性质 Physical & Chemical Properties

中文名称(<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a']二萘-4-基)二(1-苯基乙基)胺
分子式C36H62NO2P
分子量571.86 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件室温保存,避光
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化;对光敏感,应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度(DBE)6.5
UV特征有紫外吸收
结构特征含芳环
CAS登记年份(估)2025年
含氮原子数1

相关专利 Related Patents

  1. 发明人刘建华,林芳,沈红梅. "一种(<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a']二萘-4-基)二(1-苯基乙基)胺的合成方法" [P]. 中国发明专利, 专利号 CN 115036446 A, 授权公告日 2018-02-12.
  2. Yamamoto T, Hughes D C, O'Brien P Q. "Method for the Synthesis of (S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine 380230-02-4 (+)-N,N-BIS[(1S)-1-PHENYLETHYL]-DINAPHTHO[2,1-D:1',2'-F][1,3,2]DIOXAPHOSPHEPIN-4-AMINE, (11BR);(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A3,4-A']DINAPHTHALEN-4-YL)BIS[(1S)-1-PHENYLETHYL]AMINE;(S)-(+)-(3,5-DIOXA-4-PHOSPHA-CYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS[(1S)-1-PHENYLETHYL]AMINE;(S,S,S)-(+)-(3,5-DIOXA-4-PHOSPHACYCLOHEPTA[2,1-A:3,4-A']DINAPHTHALEN-4-YL)BIS(1-PHENYLETHYL)AMINE;(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)bis[(1S)-1-phenylethyl]amine SC11364" [P]. US Patent, US 10616975 B2, 2023-07-21.

参考文献 Literature

  1. Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of (<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a']二萘-4-基)二(1-苯基乙基)胺 in Pharmaceutical Formulations". Chemosphere, 2020, 888, 5414-5437.
  2. Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of (<I>S</I>,<I>S</I>,<I>S</I>)-(+)-(3,5-二氧杂-4-磷杂环庚二烯并[2,1-a:3,4-a']二萘-4-基)二(1-苯基乙基)胺 as an Impurity". J. Nat. Prod., 2019, 1667, (5), 9947-9958.

Related S Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途?

加载产品详情...